0
Arcellx, Inc. Banner Image

Arcellx, Inc.

  • Ticker ACLX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arcellx, Inc. Logo Image
  • 51-200 Employees
  • Based in Gaithersburg, Maryland
Arcellx, Inc. is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx believes that cell therapies are one of the forward pillars of medicine and Arcellx's mission is to advance humanity by developing cell therapies that are safer, more effective, and more broadly accessibleMore. Arcellx's lead product candidate, CART-ddBCMA, is being developed for the treatment of relapsed or refractory multiple myeloma (r/r MM) in an ongoing Phase 2 study. CART-ddBCMA has been granted Fast Track, Orphan Drug, and Regenerative Medicine Advanced Therapy designations by the U.S. Food and Drug Administration.
Arcellx, Inc.

Most Recent Annual Report

Arcellx, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Arcellx, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!